Galanis, Allison <br/><br/>
Inhibition of c-Kit by tyrosine kinase inhibitors.  [electronic resource] 

 -  Haematologica  Mar 2015 
 - e77-9 p.  digital 
<br/><br/> Publication Type: Letter; Research Support, N.I.H., Extramural 
<br/><br/><label>ISSN: </label>1592-8721 
<br/><br/><label>Standard No.: </label>10.3324/haematol.2014.117028  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aminopyridines--therapeutic use<br/>Antineoplastic Agents--therapeutic use<br/>Benzothiazoles--therapeutic use<br/>Biomarkers--analysis<br/>Bone Marrow--drug effects<br/>Cell Line, Tumor<br/>Clinical Trials as Topic<br/>Dasatinib<br/>Gene Expression<br/>Hair--drug effects<br/>Hematopoietic Stem Cells--drug effects<br/>Humans<br/>Indazoles<br/>Leukemia, Myeloid, Acute--drug therapy<br/>Niacinamide--analogs & derivatives<br/>Phenylurea Compounds--therapeutic use<br/>Pigmentation--drug effects<br/>Protein Kinase Inhibitors--therapeutic use<br/>Proto-Oncogene Proteins c-kit--antagonists & inhibitors<br/>Pyrimidines--therapeutic use<br/>Pyrroles--therapeutic use<br/>Sorafenib<br/>Sulfonamides--therapeutic use<br/>Thiazoles--therapeutic use<br/>fms-Like Tyrosine Kinase 3--antagonists & inhibitors